Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:OCEA

Ocean Biomedical (OCEA) Stock Price, News & Analysis

About Ocean Biomedical Stock (NASDAQ:OCEA)

Advanced Chart
Remove Ads

Key Stats

Today's Range
$0.55
$0.67
50-Day Range
N/A
52-Week Range
$0.05
$3.85
Volume
58,009 shs
Average Volume
13.33 million shs
Market Capitalization
$1.72 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Aesther Healthcare Acquisition Corp. entered into definitive merger agreement with Ocean Biomedical, Inc.

Remove Ads

Ocean Biomedical Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
12th Percentile Overall Score

OCEA MarketRank™: 

Ocean Biomedical scored higher than 12% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Ocean Biomedical.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Ocean Biomedical is -0.06, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Ocean Biomedical is -0.06, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Percentage of Shares Shorted

    0.19% of the float of Ocean Biomedical has been sold short.
  • Short Interest Ratio / Days to Cover

    Ocean Biomedical has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Ocean Biomedical has recently decreased by 96.08%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Ocean Biomedical does not currently pay a dividend.

  • Dividend Growth

    Ocean Biomedical does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.19% of the float of Ocean Biomedical has been sold short.
  • Short Interest Ratio / Days to Cover

    Ocean Biomedical has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Ocean Biomedical has recently decreased by 96.08%, indicating that investor sentiment is improving significantly.
  • News Coverage This Week

    MarketBeat has tracked 7 news articles for Ocean Biomedical this week, compared to 1 article on an average week.
  • Search Interest

    Only 3 people have searched for OCEA on MarketBeat in the last 30 days. This is a decrease of -87% compared to the previous 30 days.
  • MarketBeat Follows

    6 people have added Ocean Biomedical to their MarketBeat watchlist in the last 30 days. This is an increase of 20% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Ocean Biomedical insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    73.50% of the stock of Ocean Biomedical is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 24.55% of the stock of Ocean Biomedical is held by institutions.

  • Read more about Ocean Biomedical's insider trading history.
Receive OCEA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ocean Biomedical and its competitors with MarketBeat's FREE daily newsletter.

OCEA Stock News Headlines

Ocean Biomedical Inc.
Elon Tax Shock?
Elon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax authorities have bought a powerful new AI supercomputer, worth millions of dollars. It's the most advanced technology offered by AI giant Nvidia. And it's almost certainly going to be used to advance Elon Musk's real agenda with DOGE... the massive, rapid roll out of AI across the entire federal government.
Ocean Biomedical granted notice of grant on patent right by CNIPA
Four board members to exit troubled RI biotech
See More Headlines

OCEA Stock Analysis - Frequently Asked Questions

Ocean Biomedical, Inc. (NASDAQ:OCEA) announced its quarterly earnings results on Monday, January, 13th. The company reported ($0.20) earnings per share for the quarter.

Ocean Biomedical (OCEA) raised $22 million in an IPO on the week of April 18th 2022. The company issued 2,000,000 shares at a price of $10.00-$12.00 per share. Roth Capital Partners and JonesTrading served as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Ocean Biomedical investors own include Meta Platforms (META), Tesla (TSLA), Advanced Micro Devices (AMD), Alphabet (GOOG), NVIDIA (NVDA), JPMorgan Chase & Co. (JPM) and Home Depot (HD).

Company Calendar

Last Earnings
1/13/2025
Today
4/01/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:OCEA
Web
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-114,470,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
($2.62) per share
Price / Book
-0.02

Miscellaneous

Free Float
9,240,000
Market Cap
$1.72 million
Optionable
Optionable
Beta
1.31
The 10 Best Stocks to Own: Spring 2025 Cover

Discover the 10 best stocks to own in Spring 2025, carefully selected for their growth potential amid market volatility. This exclusive report highlights top companies poised to thrive in uncertain economic conditions—download now to gain an investing edge.

Get This Free Report

This page (NASDAQ:OCEA) was last updated on 4/1/2025 by MarketBeat.com Staff
From Our Partners